Forefront Lecture by Dr. Art Poon

Art Poon, PhD, is an Associate Research Scientist (bioinformatics) in the Laboratory Program at the BC Centre for Excellence in HIV/AIDS. His work involves developing, testing, and implementing computational and statistical methods for HIV-1 genetic sequence analysis. His research interests include virus evolution, phylogenetics, population genetics, bioinformatics, machine learning, software development, and parallel computing.

While working as a Post-Doctoral Employee at the University of California, San Diego School of Medicine, Dr. Poon co-developed HYPHY, a free multiplatform computational phylogenetics software package intended to perform maximum likelihood analyses of genetic sequence data. This software is equipped with tools to test various statistical hypotheses with and has been cited by over 350 peer-reviewed scientific journal articles.


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below